Most Popular in Regulatory
- 1Could the FDA Sunscreen Monograph See a New Addition?
- 2EPA Eyes 20 Chemicals for High Priority Risk Evaluation, ACC Responds
- 3DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol
- 4Into the Weeds: Walking the Regulatory Line of CBD in Cosmetics
- 5FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 6[podcast] Why the FDA Disallows Europe’s Sunscreens
- 7EU Effectively Bans D4 and D5 in Wash-off Products
- 8The INCI Name Game: A Commentary
- 9Korean Cosmetic Regulations
- 10Dubai Cracks Down on Banned Substances in Cosmetics
Recent in Regulatory (page 38 of 38)
Oct 28, 2011 | David C. Steinberg, Steinberg & Associates
The newest regulations and comments on sunscreens from the US Food and Drug Administration (FDA) were officially published in the Federal Register on June 17, 2011, and will go into effect June 17, 2012.
EU Regulatory Update: The Individual Safety Assessment–a Practical Approach towards Regulation (EC) No 1223/2009
Oct 25, 2011 | Annelie Struessmann, PhD, CONUSBAT
The new Cosmetics Regulation (EC) No. 1223/2009 defined the format of the Cosmetic Product Safety Report (CPSR) in the Regulation’s Annex I. Accordingly, the information for documenting the product’s safety is to be listed in a part A of the CPSR, and this needs to include the toxicological profiles of the ingredient substances, their physical and chemical characteristics, impurities, trace components, as well as their exposure criteria in use.
Oct 10, 2011
NSF International’s American National Standard for Personal Care Products Containing Organic Ingredients (NSF/ANSI 305) has been expanded to allow plant-based ingredients that are certified to European Union (EU) organic regulations.
Oct 5, 2011 | Dominique Lutz, Julie Ongenaed and Celine Guy, HelioScreen Labs
UVA protection is part of the mandatory testing for claiming broad-spectrum sun protection. A worldwide standardization is in development with the ISO TC217, expected for UVA testing 2012. The FDA has issued a final rule following Colipa’s proposed UVA in vitro method. While this rule establishes UVA labeling and testing, inconsistencies remain. This study compares the critical wavelength in roughness and application before and after two levels of UV doses.